Rolling record / ARQ 63 Concerning · ▲ +2 7-day 3595 events in window / as of 02 Oct 2026
ARQAI Risk Quotient
medicine 19.4 Danger

Insilico Medicine Takes Its AI-Discovered Drug Into Phase III Trials

This highlights AI's role in accelerating drug discovery, advancing medicine with potential for faster therapeutic breakthroughs.

This highlights AI’s role in accelerating drug discovery, advancing medicine with potential for faster therapeutic breakthroughs.

Auto-scored: A real but partial step in beneficial AI application with no identified risk.